首页> 美国卫生研究院文献>Molecular Therapy. Methods Clinical Development >Suppression of leaky expression of adenovirus genes by insertion of microRNA-targeted sequences in the replication-incompetent adenovirus vector genome
【2h】

Suppression of leaky expression of adenovirus genes by insertion of microRNA-targeted sequences in the replication-incompetent adenovirus vector genome

机译:通过将microRNA靶向序列插入无复制能力的腺病毒载体基因组中抑制腺病毒基因的漏表达

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Leaky expression of adenovirus (Ad) genes occurs following transduction with a conventional replication-incompetent Ad vector, leading to an induction of cellular immunity against Ad proteins and Ad protein-induced toxicity, especially in the late phase following administration. To suppress the leaky expression of Ad genes, we developed novel Ad vectors by incorporating four tandem copies of sequences with perfect complementarity to miR-122a or miR-142-3p into the 3′-untranslated region (UTR) of the E2A, E4, or pIX gene, which were mainly expressed from the Ad vector genome after transduction. These Ad vectors easily grew to high titers comparable to those of a conventional Ad vector in conventional 293 cells. The leaky expression of these Ad genes in mouse organs was significantly suppressed by 2- to 100-fold, compared with a conventional Ad vector, by insertion of the miRNA-targeted sequences. Notably, the Ad vector carrying the miR-122a–targeted sequences into the 3′-UTR of the E4 gene expressed higher and longer-term transgene expression and more than 20-fold lower levels of all the Ad early and late genes examined in the liver than a conventional Ad vector. miR-122a–mediated suppression of the E4 gene expression in the liver significantly reduced the hepatotoxicity which an Ad vector causes via both adaptive and non-adaptive immune responses.
机译:腺病毒(Ad)基因的泄漏在常规复制能力不佳的Ad载体转导后发生,导致诱导针对Ad蛋白的细胞免疫和Ad蛋白诱导的毒性,尤其是在给药后的晚期。为了抑制Ad基因的漏表达,我们通过将四个与miR-122a或miR-142-3p完美互补的串联复制序列串联到E2A,E4、3'的3'-非翻译区(UTR)中,从而开发了新颖的Ad载体或pIX基因,主要在转导后从Ad载体基因组表达。这些Ad载体易于在常规293细胞中生长至与常规Ad载体相当的高滴度。通过插入miRNA靶向序列,与常规Ad载体相比,这些Ad基因在小鼠器官中的泄漏表达被显着抑制了2到100倍。值得注意的是,携带miR-122a靶向序列进入E4基因3'-UTR的Ad载体表现出较高和较长期的转基因表达,而在此研究中检测到的所有Ad早期和晚期基因的表达水平降低了20倍以上。肝脏比传统的Ad载体要好。 miR-122a介导的肝脏E4基因表达的抑制作用大大降低了Ad载体通过适应性和非适应性免疫反应引起的肝毒性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号